Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity

• Published in: Clinical microbiology reviews Vol. 33; no. 2
• Main Authors: Lam, Eugene, Rosen, Jennifer B, Zucker, Jane R
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 18.03.2020
• Subjects: Disease Outbreaks - prevention & control; Humans; Immunization Programs; Measles-Mumps-Rubella Vaccine - administration & dosage; Measles-Mumps-Rubella Vaccine - immunology; Mumps - epidemiology; Mumps - prevention & control; Review; Vaccination Coverage; vaccine effectiveness; genomic diversity; outbreaks; vaccine efficacy; mumps
• ISSN: 0893-8512; 1098-6618
• DOI: 10.1128/CMR.00151-19

Mumps is an acute viral infection characterized by inflammation of the parotid and other salivary glands. Persons with mumps are infectious from 2 days before through 5 days after parotitis onset, and transmission is through respiratory droplets. Despite the success of mumps vaccination programs in the United States and parts of Europe, a recent increase in outbreaks of mumps virus infections among fully vaccinated populations has been reported. Although the effectiveness of the mumps virus component of the measles-mumps-rubella (MMR) vaccine is suboptimal, a range of contributing factors has led to these outbreaks occurring in high-vaccination-coverage settings, including the intensity of exposure, the possibility of vaccine strain mismatch, delayed implementation of control measures due to the timeliness of reporting, a lack of use of appropriate laboratory tests (such as reverse transcription-PCR), and time since last vaccination. The resurgence of mumps virus infections among previously vaccinated individuals over the past decade has prompted discussions about new strategies to mitigate the risk of future outbreaks. The decision to implement a third dose of the MMR vaccine in response to an outbreak should be considered in discussions with local public health agencies. Traditional public health measures, including the isolation of infectious persons, timely contact tracing, and effective communication and awareness education for the public and medical community, should remain key interventions for outbreak control. Maintaining high mumps vaccination coverage remains key to U.S. and global efforts to reduce disease incidence and rates of complications.